Minride P M 2mg/500mg/15mg Tablet
Marketer
Morecare Pharmatec Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Minride P M 2mg/500mg/15mg Tablet
GlucoTrim Triple Action 2mg/500mg/15mg tablets offer combined therapy for effective blood glucose management. This medication, used alongside diet and exercise, enhances glycemic control in adult type 2 diabetics. It promotes efficient insulin use, consequently reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen for GlucoTrim Triple Action tablets; take with food to minimize digestive discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; never double the dose to compensate. Excessive intake can result in hypoglycemia. Concurrent use with other diabetes medications, alcohol, or skipped meals raises hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or cardiac conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption to mitigate potential side effects.
Primary Ingredients of Minride P M 2mg/500mg/15mg Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Minride P M 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Minride P M 2mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the entire tablet; do not chew, crush, or fracture it. The Minride P M 2mg/500mg/15mg Tablet should be administered with a meal.
Common Side effects of Minride P M 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Minride P M 2mg/500mg/15mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for Minride P M 2mg/500mg/15mg Tablets. Ingest the tablets whole; do not crush, chew, or break them. Administer this medication with food.
How Minride P M 2mg/500mg/15mg Tablet works:
Minride P M 2mg/500mg/15mg tablets contain glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their combined action improves blood sugar management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Minride P M 2mg/500mg/15mg Tablet with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Minride P M 2mg/500mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Minride P M 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Minride P M 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult your physician for guidance. This medication is contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Minride P M 2mg/500mg/15mg tablets cautiously, potentially requiring dose modification. A physician's consultation is advised. Minride P M 2mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Minride P M 2mg/500mg/15mg Tablet :
Should you forget a Minride P M 2mg/500mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Minride P M 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently